Comparison between SCOT-15® and Perfadex® as lung preservation solutions

A. Olland, C. Meers, M. Benahmed, K. Elbayed, S. Wauters, E. Verbeken, G. Verleden, I. Namer, D. Van Raemdonck (Leuven, Belgium; Strasbourg, France)

Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations
Session: Immunobiology in the transplanted lung: experimental and clinical evaluations
Session type: Oral Presentation
Number: 222

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Olland, C. Meers, M. Benahmed, K. Elbayed, S. Wauters, E. Verbeken, G. Verleden, I. Namer, D. Van Raemdonck (Leuven, Belgium; Strasbourg, France). Comparison between SCOT-15® and Perfadex® as lung preservation solutions. Eur Respir J 2011; 38: Suppl. 55, 222

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011


Evaluation of pulmonary diffusion: TLCO or KCO?
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010

Ways to shorten the lung clearance index measurement ΙΙ – How long to wash?
Source: Annual Congress 2012 - New developments in paediatric respiratory physiology
Year: 2012

Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler®
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012

Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler®
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011


Transcutaneous measurement of pCO2 (ptcCO2): Time delay from change in alveolar pCO2 to first response in ptcCO2
Source: Annual Congress 2011 - Sleep and weight: heavy under pressure
Year: 2011



Alterations in ORMDL expression in experimental esthma
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012

Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010


LungPoint® – A new approach to peripheral lung lesions
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010


Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system]
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Curette lavage fluid analysis of EGFR, KRAS, and P53 mutations in lung cancer patients
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011

Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011

Clinical decision making in alpha1 antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV1 decline
Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases
Year: 2010

Detection of lung cancer on CXR – A comparison of radiologist‘s performance
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010


Study of the use of Chartis® pulmonary assessment system to optimize subject selection for endobronchial lung volume reduction (ELVR) – Results and subgroup analysis
Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Year: 2011

Double tracer gas single breath washout – Comparison with conventional lung function tests in children with and without cystic fibrosis
Source: Annual Congress 2011 - Advances in lung function testing from infancy to adulthood
Year: 2011

EGFR, HER2 and KRAS mutational status according to adenocarcinoma patterns/sub-types
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011

Ways to shorten the lung clearance index measurement I – Are three measurements needed?
Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement
Year: 2012


The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011

Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis –
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010